SWOG clinical trial number
CTSU/EA1131
A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Breast Cancer following Neoadjuvant Chemotherapy
Open
Phase
Abbreviated Title
Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative BC following Neoadjuvant Chemotherapy
Status Notes
ECOG-ACRIN activated: 4/29/2015
SWOG activated: 7/24/19
SWOG activated: 7/24/19
Activated
07/24/2019
Participants
ALL NATIONAL CLINICAL TRIALS NETWORK MEMBERS LISTED ON TITLE PAGE
Research committees
Breast Cancer
Eligibility Criteria Expand/Collapse
Eligibility criteria are accessible from the protocol abstract page on the CTSU website (http://www.ctsu.org).
Other Clinical Trials
SWOG Clinical Trial Number
SWOG-7436
Combined Modality Therapy of Breast Carcinoma Phase III
Research Committee(s)
Breast Cancer
Activated
01/09/1975
Closed
07/18/1979
Accrual
100%
Closed
Phase
III
Published
SWOG Clinical Trial Number
SWOG-7827
Combined Modality Therapy For Breast Carcinoma Phase III
Research Committee(s)
Breast Cancer
Activated
07/16/1979
Closed
08/01/1989
Accrual
100%
Closed
Phase
III
Published
SWOG Clinical Trial Number
SWOG-8312
Megestrol Acetate and Aminoglutethimide/ Hydrocortisone In Sequence or in Combination as Second-Line Endocrine Therapy of Estrogen Receptor Positive Metastatic Breast Cancer
Research Committee(s)
Breast Cancer
Activated
05/04/1984
Closed
11/15/1990
Accrual
96%
Closed
Phase
Published